Page last updated: 2024-09-04

ter 286 and Neoplasm Metastasis

ter 286 has been researched along with Neoplasm Metastasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boulos, L; Brown, GL; Jameson, AJ; Keck, JG; Laxa, B; Parra, R; Patel, K; Rosen, LS; Wiggins, L	1

Trials

1 trial(s) available for ter 286 and Neoplasm Metastasis

Article	Year
Phase 1 study of TLK286 (Telcyta) administered weekly in advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jun-01, Volume: 10, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Cytotoxins; Female; Follow-Up Studies; Glutathione; Humans; Male; Maximum Tolerated Dose; Middle Aged; Models, Chemical; Neoplasm Metastasis; Neoplasms; Time Factors	2004

Article

Year

Phase 1 study of TLK286 (Telcyta) administered weekly in advanced malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jun-01, Volume: 10, Issue:11

Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Cytotoxins; Female; Follow-Up Studies; Glutathione; Humans; Male; Maximum Tolerated Dose; Middle Aged; Models, Chemical; Neoplasm Metastasis; Neoplasms; Time Factors

2004